During the European Federation of National Associations of Orthopaedics and Traumatology’s (EFFORT) yearly conference, doctors highlighted the risks of metal-on-metal hip replacements, especially for women aged 55 and older. Many patients with hip devices such as the BioMet M2a Magnum hip replacement have been complained of serious side effects.
Doctors at the conference suggested that components of metal-on-metal hip replacements could be to blame for increased injuries. They also commented that studies will need to be done every 5 to 10 years to determine the risk of cancer associated with the devices after many caused toxic levels of metal to enter the bloodstream.
Many hip implant patients have filed BioMet M2a Magnum lawsuits after suffering severe complications, including corrosion, fretting and tissue damage, which often require revision surgery to correct. A 2011 study found that BioMet hip implants had a yearly revision surgery rate that is much higher than other hip replacements.